Roemer Alan S.

CIK 00016430703 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001643070

Recent Transactions

50 trades

Award
IN8BIO, INC.$INAB
Stock Option (right to buy)
2025-05-08+63,150→ 63,150 total
Exercise/Conversion
IN8BIO, INC.$INAB
Series A Warrants (right to buy)
2025-04-30−102,459→ 0 total
Exercise/Conversion
IN8BIO, INC.$INAB
Common Stock
2025-04-30$0.18/sh+102,459→ 387,489 total
Exercise/Conversion
IN8BIO, INC.$INAB
Common Stock
2025-04-30$0.18/sh+11,000→ 398,489 total
Exercise/Conversion
IN8BIO, INC.$INAB
Series B Warrants (right to buy)
2025-04-30−11,000→ 0 total
Award
IN8BIO, INC.$INAB
Series B Warrants (right to buy)
2025-04-27+91,459→ 91,459 total
Disposition to Issuer
IN8BIO, INC.$INAB
Series B Warrants (right to buy)
2025-04-27−102,459→ 0 total
Award
IN8BIO, INC.$INAB
Series A Warrants (right to buy)
2025-04-27+102,459→ 102,459 total
Disposition to Issuer
IN8BIO, INC.$INAB
Series A Warrants (right to buy)
2025-04-27−102,459→ 0 total
Award
IN8BIO, INC.$INAB
Series B Warrants (right to buy)
2025-04-27+11,000→ 11,000 total
Award
IN8BIO, INC.$INAB
Stock Option (right to buy)
2024-12-19+93,242→ 93,242 total
Disposition to Issuer
IN8BIO, INC.$INAB
Series A Warrants (right to buy)
2024-10-04−102,459→ 0 total
Award
IN8BIO, INC.$INAB
Series A Warrants (right to buy)
2024-10-04+102,459→ 102,459 total
Award
IN8BIO, INC.$INAB
Series C Warrants (right to buy)
2024-10-04+126,582→ 126,582 total
Award
IN8BIO, INC.$INAB
Common Stock
2024-10-04+126,582→ 285,030 total
Award
IN8BIO, INC.$INAB
Stock Option (right to buy)
2024-06-12+33,650→ 33,650 total
Award
IN8BIO, INC.$INAB
Series B Warrants (right to buy)
2023-12-13+102,459→ 102,459 total
Award
IN8BIO, INC.$INAB
Common Stock
2023-12-13+102,459→ 158,448 total
Award
IN8BIO, INC.$INAB
Series A Warrants (right to buy)
2023-12-13+102,459→ 102,459 total
Sale
NexImmune, Inc.
Common Stock
2023-11-22$1.94/sh−3,992→ 0 total
Sale
NexImmune, Inc.
Common Stock
2023-11-21$2.16/sh−3,833→ 3,992 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-07-05+44,983→ 44,983 total
Award
IN8BIO, INC.$INAB
Stock Option (right to buy)
2023-06-15+85,000→ 85,000 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+3,856→ 3,856 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−61,678→ 0 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−3,856→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+61,678→ 61,678 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−9,556→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+9,556→ 9,556 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+23,122→ 23,122 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−23,122→ 0 total
Purchase
IN8BIO, INC.$INAB
Common Stock
2022-08-16$1.90/sh+26,315→ 55,989 total
Award
NexImmune, Inc.
Stock Option (Right to Buy)
2022-06-13+61,678→ 61,678 total
Award
IN8BIO, INC.$INAB
Stock Option (right to buy)
2022-06-01+10,500→ 10,500 total
Award
IN8BIO, INC.$INAB
Stock Option (right to buy)
2022-06-01+13,500→ 13,500 total
Exercise/Conversion
NexImmune, Inc.
Common Stock
2021-12-21$2.58/sh+12,634→ 153,252 total
Exercise/Conversion
NexImmune, Inc.
Common Stock
2021-12-21$4.31/sh+42,389→ 195,641 total
Exercise/Conversion
NexImmune, Inc.
Stock Option (right to buy)
2021-12-21−12,634→ 0 total
Exercise/Conversion
NexImmune, Inc.
Common Stock
2021-12-21$2.42/sh+12,634→ 140,618 total
Exercise/Conversion
NexImmune, Inc.
Stock Option (right to buy)
2021-12-21−42,389→ 3,856 total
Exercise/Conversion
NexImmune, Inc.
Stock Option (right to buy)
2021-12-21−12,634→ 0 total
Award
IN8BIO, INC.$INAB
Stock Option (right to buy)
2021-11-19+86,258→ 86,258 total
Award
IN8BIO, INC.$INAB
Stock Option (right to buy)
2021-07-29+10,500→ 10,500 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+4,110→ 89,126 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+85,016→ 85,016 total
Conversion
NexImmune, Inc.
Series A3 Preferred Stock
2021-02-17−26,590→ 0 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+26,590→ 115,716 total
Conversion
NexImmune, Inc.
Convertible Promissory Note
2021-02-17→ 0 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+12,268→ 127,984 total
Conversion
NexImmune, Inc.
Series A Preferred Stock
2021-02-17−85,016→ 0 total

Companies

Recent Filings

Address

C/O IN8BIO, INC. 350 5TH AVE. SUITE 5330

NEW YORK, NY, 10118

View on SEC.gov